Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xinyang Tablet in Chronic Heart Failure due to Coronary Heart Disease (Phase II)
CTR20251170Phase 2Active
- Sponsor
- First Affiliated Hospital of Guangzhou University of Chinese Medicine
- Start
- Aug 2025
- Countries
- 1
01
Overview
A Phase 2 trial of Xinyang Pian in chronic heart failure (CHF), coronary arteriosclerosis, sponsored by First Affiliated Hospital of Guangzhou University of Chinese Medicine. Started Aug 2025; status: active.
02
Drugs
Xinyang Pian
03
Conditions
chronic heart failure (CHF)coronary arteriosclerosis
Beyond the preview
Go deeper on CTR20251170.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20251170.